Date of Presentation
5-2-2024 12:00 AM
College
Rowan-Virtua School of Osteopathic Medicine
Poster Abstract
Introduction: Limited data exists for patients undergoing a thoracic endovascular aortic repair (TEVAR) procedure who are older than or equal to 80 years old (YO). This study sought to examine the national inpatient sample (NIS) database to describe in-hospital outcomes among these older patients.
Methods: The NIS was searched for hospitalizations of adults who underwent a TEVAR procedure in 2019 and 2020. The study compared those aged 80 YO and over to those younger than 80 YO. The primary outcome was inpatient mortality. Secondary outcomes included hospital length of stay (LOS), and total hospital charges (TOTHCG).
Results: This study included 696 patients who underwent TEVAR, of which 35 (5.02%) were 80 years or older. Patients who had a TEVAR and were 80 years and older had higher prevalence of hypertension (57.6% vs. 50.3%, p <0.001), diabetes mellitus (34.4% vs. 27.3%, p <0.001), and chronic kidney disease (5.3% vs. 4.2%, p <0.001). In-hospital mortality was higher among the older cohort (5.35% vs. 4.0% p <0.001). On linear regression analysis, increased age was associated with increased in-hospital mortality (p <0.001). On multivariable regression, age greater than or equal to 80 YO was associated with higher odds of inpatient mortality (OR 1.103, 95% CI 1.026-1.186, p <0.001). Additionally, older patients who underwent TEVAR pay significantly less TOTHCG ($359,887 vs. $462,216, p <0.001) with shorter LOS (12.8days vs. 15.7days, p <0.001).
Conclusion: In this nationally representative population‐based study, aging was associated with higher mortality and worse outcomes among patients undergoing a TEVAR procedure.
Keywords
TEVAR, NIS, hospital mortality, LOS, TOTHCG, Treatment Outcome, National Inpatient Sample, Endovascular Aneurysm Repair, Length of Stay, Aged
Disciplines
Cardiology | Cardiovascular Diseases | Health and Medical Administration | Medicine and Health Sciences | Patient Safety | Surgery | Surgical Procedures, Operative | Therapeutics
Document Type
Poster
Included in
Cardiology Commons, Cardiovascular Diseases Commons, Health and Medical Administration Commons, Patient Safety Commons, Surgery Commons, Surgical Procedures, Operative Commons, Therapeutics Commons
Outcomes of Thoracic Endovascular Aortic Repair (TEVAR) Procedure in Octogenarians, Nonagenarians and Centenarians: A Population-Based Study
Introduction: Limited data exists for patients undergoing a thoracic endovascular aortic repair (TEVAR) procedure who are older than or equal to 80 years old (YO). This study sought to examine the national inpatient sample (NIS) database to describe in-hospital outcomes among these older patients.
Methods: The NIS was searched for hospitalizations of adults who underwent a TEVAR procedure in 2019 and 2020. The study compared those aged 80 YO and over to those younger than 80 YO. The primary outcome was inpatient mortality. Secondary outcomes included hospital length of stay (LOS), and total hospital charges (TOTHCG).
Results: This study included 696 patients who underwent TEVAR, of which 35 (5.02%) were 80 years or older. Patients who had a TEVAR and were 80 years and older had higher prevalence of hypertension (57.6% vs. 50.3%, p <0.001), diabetes mellitus (34.4% vs. 27.3%, p <0.001), and chronic kidney disease (5.3% vs. 4.2%, p <0.001). In-hospital mortality was higher among the older cohort (5.35% vs. 4.0% p <0.001). On linear regression analysis, increased age was associated with increased in-hospital mortality (p <0.001). On multivariable regression, age greater than or equal to 80 YO was associated with higher odds of inpatient mortality (OR 1.103, 95% CI 1.026-1.186, p <0.001). Additionally, older patients who underwent TEVAR pay significantly less TOTHCG ($359,887 vs. $462,216, p <0.001) with shorter LOS (12.8days vs. 15.7days, p <0.001).
Conclusion: In this nationally representative population‐based study, aging was associated with higher mortality and worse outcomes among patients undergoing a TEVAR procedure.